Diabetes
Feature
‘Smart’ insulin pen with CGM first to launch in emerging field
InPen with Real-Time Guardian Connect CGM Data brings together Medtronic’s technologies as the “smart pen” landscape expands for patients with...
Conference Coverage
First SGLT1/2 inhibitor shows ‘spectacular’ phase 3 safety and efficacy in T2D
A pair of pivotal trials showed safety and efficacy for sotagliflozin for patients with type 2 diabetes, including novel benefits from an SGLT...
Feature
Lancet panel calls for urgent global action to combat diabetes
Of the 463 million people with diabetes worldwide in 2019, 80% live in low- and middle-income countries.
Guidelines
New guidelines address diabetes management in kidney disease
The Kidney Disease: Improving Global Outcomes synopsis document is aimed at primary care physicians and nonnephrology specialists, as well as...
Conference Coverage
Don’t miss cardiovascular risk factors in transgender patients
Transgender patients seeking gender affirming hormone therapy showed an increased risk of cardiovascular disease at baseline
From the Journals
Semaglutide shows promise in NASH phase 2 study
The drug “bodes well for further study” in a condition with no FDA approved treatments.
Clinical Inquiries
Do electronic reminder systems help patients with T2DM to lose weight?
EVIDENCE-BASED ANSWER: PROBABLY NOT—but they may augment self-management. Four-component telehealth systems—including electronic reminders,...
From the Journals
PCI success vs. meds only in diabetes may depend on LDL-C control
PCI and LDL-lowering therapy work as a team to cut clinical risk in patients with diabetes and stable coronary disease, but succeed only if LDL-C...
Med Tech Report
Medication adherence challenges and helpers
Thankfully, there are tools designed to help remind patients of what they need to take and when.
Guidelines
First-of-its kind guideline on lipid monitoring in endocrine diseases
A new guideline from the Endocrine Society calls for heightened awareness of cholesterol management and treatment in endocrine diseases beyond...
Feature
Diabetes screening program in optometry offices to expand
Success of pilot program sponsored by VSP Vision Care leads to expansion into Ohio optometry offices.